Um unsere Website nutzerfreundlicher, effektiver und sicherer zu machen, verwenden wir Cookies. Durch die weitere Nutzung der Website stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies erhalten Sie in unserer Datenschutzerklärung.

Mehr Informationen
Info

Herzinfarktregister Brandenburg

Herzinfarktregister Brandenburg

Suchen

Publikationen 2026

  1. Sasko B, Kelesidis T, Kostin S, Scharow L, Mueller R, Jaensch M, Wintrich J, Christ M, Ritter O, Ukena C, Pagonas N. Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection fraction. Clin Res Cardiol. 2026 Feb;115(2):232-240. doi: 10.1007/s00392-024-02583-3
  2. Füller D, Ritter O, Tchaikovski V. Severe paravalvular detachment of a bioprosthetic aortic valve in atypical infective endocarditis. Eur Heart J Case Rep. 2026 Mar 12;10(3):ytag182. doi: 10.1093/ehjcr/ytag182

Publikationen 2025

  1. Sasko B, Scharow L, Mueller R, Jaensch M, Dammermann W, Seibert FS, Hillmeister P, Buschmann I, Christ M, Ritter O, Hamdani N, Ukena C, Westhoff TH, Kelesidis T, Pagonas N. Reduced high-density lipoprotein antioxidant function in patients with coronary artery disease and acute coronary syndrome. JCI Insight. 2025 Mar 24;10(6):e187889. doi: 10.1172/jci.insight.187889
  2. Füller D, Sasko B, Ritter O. Genetic associations with socioeconomic status are limited in explaining the socioeconomic health gradient. Proc Natl Acad Sci U S A. 2025 May 27;122(21):e2505061122. doi: 10.1073/pnas.2505061122
  3. Füller D, Andresen-Bundus H, Pagonas N, Jaehn P, Ukena C, Gödde K, Holmberg C, Ritter O, Sasko B. Adverse socioeconomic factors are associated with a widening gap in one-year health-related quality of life after acute myocardial infarction. Sci Rep. 2025 Jun 5;15(1):19791. doi: 10.1038/s41598-025-04604-1
  4. Sasko B, Pagonas N, Christ M, Wintrich J, Ritter O, Ukena C, Sultana I, Delalat S, El-Battrawy I, Kelesidis T, Hamdani N. Oxidized high-density lipoprotein associates with cardiometabolic dysfunction in coronary artery disease and acute coronary syndrome. J Intern Med. 2025 Nov;298(5):464-477. doi: 10.1111/joim.70019

Publikationen 2024

  1. Füller D, Liu C, Ko YA, Alkhoder AA, Desai SR, Almuwaqqat Z, Patel SA, Ejaz K, Kauser T, Martini MA, Alvi Z, Mehta PK, Sperling LS, Quyyumi AA. Soluble urokinase Plasminogen Activator Receptor (suPAR) mediates the effect of a lower education level on adverse outcomes in patients with coronary artery disease. Eur J Prev Cardiol. 2024 Mar 27;31(5):521-528. doi: 10.1093/eurjpc/zwad311
  2. Borlich M, Zeymer U, Wienbergen H, Hobbach HP, Cuneo A, Bekeredjian R, Ritter O, Hailer B, Hertting K, Hennersdorf M, Scholtz W, Lanzer P, Mudra H, Schwefer M, Schwimmbeck PL, Liebetrau C, Thiele H, Claas C, Riemer T, Zahn R, Iden L, Richardt G, Toelg R. Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI Trial. Cardiol Ther. 2024 Mar;13(1):89-101. doi: 10.1007/s40119-023-00343-4
  3. Füller D. Investigating the biological effects of socioeconomic adversity in cancer. Clin Transl Disc. 2024;4:e284. doi: 10.1002/ctd2.284
  4. Füller D. Trial outcome definitions require more attention. Am Heart J. 2024 Apr;270:161. doi: 10.1016/j.ahj.2024.01.002. Epub 2024 Jan 8. PMID: 38199529.
  5. Pagonas N, Mueller R, Weiland L, Jaensch M, Dammermann W, Seibert FS, Hillmeister P, Buschmann I, Christ M, Ritter O, Westhoff TH, Sasko B, Kelesidis T. Oxidized high-density lipoprotein associates with atrial fibrillation. Heart Rhythm. 2024 Apr;21(4):362-369. doi: 10.1016/j.hrthm.2023.11.024
  6. Blankenberg S, Seiffert M, Vonthein R, Baumgartner H, Bleiziffer S, Borger MA, Choi YH, Clemmensen P, Cremer J, Czerny M, Diercks N, Eitel I, Ensminger S, Frank D, Frey N, Hagendorff A, Hagl C, Hamm C, Kappert U, Karck M, Kim WK, König IR, Krane M, Landmesser U, Linke A, Maier LS, Massberg S, Neumann FJ, Reichenspurner H, Rudolph TK, Schmid C, Thiele H, Twerenbold R, Walther T, Westermann D, Xhepa E, Ziegler A, Falk V; DEDICATE-DZHK6 Trial Investigators (O. R.). Transcatheter or Surgical Treatment of Aortic-Valve Stenosis. N Engl J Med. 2024 May 2;390(17):1572-1583. doi: 10.1056/NEJMoa2400685
  7. Füller D, Liu C, Desai SR, Vatsa N, Sun YV, Quyyumi AA. Association of apolipoprotein B and apolipoprotein A1 levels with social determinants of health and coronary artery disease mortality in the United Kingdom Biobank - is there a need for consideration? Coron Artery Dis. 2024 Sep 1;35(6):509-515. doi: 10.1097/MCA.0000000000001380. Epub 2024 May 6
  8. Füller D. Can money buy health? Using a natural experiment to guide interventions to address the socioeconomic inequalities in health. Front Public Health. 2024 May 28;12:1397127. doi: 10.3389/fpubh.2024.1397127
  9. Ray KK, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Laufs U, Mostaza JM, Nanchen D, Bardet A, Lamparter M, Chhabra R, Soronen J, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL; SANTORINI Study Investigators (O. R.). Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study. Eur J Prev Cardiol. 2024 Nov 11;31(15):1792-1803. doi: 10.1093/eurjpc/zwae199

Publikationen 2023

  1. Andresen H, Pagonas N, Eisert M, Patschan D, Nordbeck P, Buschmann I, Sasko B, Ritter O., Defibrillator exchange in the elderly, Heart Rhythm O2. 2023 May 13;4(6):382-390. doi: 10.1016/j.hroo.2023.05.001. eCollection 2023 Jun. PMID: 37361620
  2. Pagonas N, Sasko B, Ritter O., Managing hypertension in the future: a multifactorial approach. Eur J Prev Cardiol. 2023 Jan 11;30(1):46-47. doi: 10.1093/eurjpc/zwac238.
  3. Patschan D, Patschan S, Matyukhin I, Hoffmeister M, Lauxmann M, Ritter O, Dammermann W., Metabolomics in Acute Kidney Injury: The Experimental Perspective. J Clin Med Res. 2023 Jun;15(6):283-291. doi: 10.14740/jocmr4913. Epub 2023 Jun 29.
  4. Patschan D, Patschan S, Matyukhin I, Ritter O, Dammermann W.Metabolomics in Acute Kidney Injury: The Clinical Perspective. J Clin Med. 2023 Jun 16;12(12):4083. doi: 10.3390/jcm12124083.
  5. Li K, Kratzmann V, Dai M, Gatzke N, Rocic P, Bramlage P, Grisk O, Lubomirov LT, Hoffmeister M, Lauxmann MA, Ritter O, Buschmann E, Bader M, Persson AB, Buschmann I, Hillmeister P.Angiotensin receptor-neprilysin inhibitor improves coronary collateral perfusion. Front Cardiovasc Med. 2023 Feb 3;9:981333. doi: 10.3389/fcvm.2022.981333. eCollection 2022.
  6. Patschan D, Erfurt S, Oess S, Lauxmann MA, Patschan S, Ritter O, Hoffmeister M. Biomarker-based prediction of survival and recovery of kidney function in acute kidney injury, Kidney Blood Press Res. 2023 Feb 9. doi: 10.1159/000528633. Online ahead of print.
  7. Jänsch M, Lubomirov LT, Trum M, Williams T, Schmitt J, Schuh K, Qadri F, Maier LS, Bader M, Ritter O. Inducible over-expression of cardiac Nos1ap causes short QT syndrome in transgenic mice, FEBS Open Bio. 2023 Jan;13(1):118-132. doi: 10.1002/2211-5463.13520. Epub 2022 Nov 27.
  8. Pagonas N, Seibert FS, Liebisch G, Seidel M, Giannakopoulos T, Sasko B, Ritter O, Babel N, Westhoff TH. Association of plasma propionate concentration with coronary artery disease in a large cross-sectional study. Front Cardiovasc Med. 2023 Feb 1;10:1063296. doi: 10.3389/fcvm.2023.1063296. eCollection 2023.
  9. Li K, Dai M, Sacirovic M, Zemmrich C, Pagonas N, Ritter O, Grisk O, Lubomirov LT, Lauxmann MA, Bramlage P, Persson AB, Buschmann E, Buschmann I, Hillmeister P. Leukocyte telomere length and mitochondrial DNA copy number associate with endothelial function in aging-related cardiovascular disease. Front Cardiovasc Med. 2023 Jun 5;10:1157571. doi: 10.3389/fcvm.2023.1157571. eCollection 2023.
  10. Merz S, Jaehn P, Pischon T, Fischer B, Wirkner K, Rach S, Guenther K, Obi N, Holmberg C; AdvanceGender Study Group. Investigating people's attitudes towards participating in longitudinal health research: an intersectionality-informed perspective. Int J Equity Health. 2023 Jan 31;22(1):23. doi: 10.1186/s12939-022-01807-0.
  11. Zeymer U, Toelg R, Wienbergen H, Hobbach HP, Cuneo A, Bekeredjian R, Ritter O, Hailer B, Hertting K, Hennersdorf M, Scholtz W, Lanzer P, Mudra H, Schwefer M, Schwimmbeck PL, Liebetrau C, Thiele H, Claas C, Riemer T, Zahn R. Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical Practice. Am J Cardiol. 2023 Feb 15;189:31-37. doi: 10.1016/j.amjcard.2022.11.009
  12. Zeymer U, Toelg R, Wienbergen H, Hobbach HP, Cuneo A, Bekeredjian R, Ritter O, Hailer B, Hertting K, Hennersdorf M, Scholtz W, Lanzer P, Mudra H, Schwefer M, Schwimmbeck PL, Liebetrau C, Thiele H, Claas C, Riemer T, Zahn R. Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany. Herz. 2023 Mar;48(2):134-140. English. doi: 10.1007/s00059-022-05099-6
  13. Füller D, Vieth SJ, Otto B. Migrant and socioeconomic status might intersect in adverse health outcomes. Front Public Health. 2023 Nov 29;11:1244612. doi: 10.3389/fpubh.2023.1244612
  14. Greffin K, Muehlan H, van den Berg N, Hoffmann W, Ritter O, Oeff M, Speerfork S, Schomerus G, Schmidt S. Measuring context that matters: validation of the modular Tele-QoL patient-reported outcome and experience measure. Qual Life Res. 2023 Nov;32(11):3223-3234. doi: 10.1007/s11136-023-03469-z
  15. Bergholz A, Jaehn P, Böckmann R, Reibis R, Spallek J, Rapp MA, Ritter O, Demmerer N, Holmberg C. Erreichbarkeit der kardiologischen Versorgungsinfrastruktur im Bundesland Brandenburg in Abhängigkeit des lokalen Versorgungsbedarfs [Access to cardiological care infrastructure in the federal state of Brandenburg considering the local care needs]. Gesundheitswesen. 2023 Dec;85(12):1157-1167. German. doi: 10.1055/a-2075-7748

Publikationen 2022

  1. Jaehn P, Andresen-Bundus H, Bergholz A, Pagonas N, Hauptmann M, Neugebauer EA, Holmberg C, Ritter O, Sasko B. Contextualising the association of socioeconomic deprivation with hospitalisation rates of myocardial infarction in a rural area in eastern Germany, Rural and Remote Health, Rural Remote Health. 2022 Apr;22(2):6658. doi: 0.22605/RRH6658. Epub 2022 Apr 8.
  2. Wang, C.; Enssle, J.; Pietzner, A.; Schmöcker, C.; Weiland, L.; Ritter, O.; Jaensch, M.; Elbelt, U.; Pagonas, N.; Weylandt, K.H, Essential Polyunsaturated Fatty Acids in Blood from Patients with and without Catheter-Proven Coronary Artery Disease; Int. J. Mol. Sci. 2022, 23, 766.
  3. Sasko B, Jaehn P, Müller R, Andresen H, Müters S, Holmberg C, Ritter O, Pagonas N, Understanding the importance of social determinants and rurality for the long-term outcome after acute myocardial infarction: study protocol for a single-centre cohort study, BMJ Open, 2022 Apr 15;12(4):e056888. doi: 10.1136/bmjopen-2021-056888
  4. Ghafoor H, Nordbeck P, Ritter O, Pauli P, Schulz SM., Can Religiosity and Social Support Explain Effects of Trait Emotional Intelligence on Health-Related Quality of Life: A Cross-Cultural Study, J Relig Health. 2022 Feb;61(1):158-174. doi: 10.1007/s10943-020-01163-9. Epub 2021 Jan 7.PMID: 33415603
  5. Lubomirov LT, Jänsch MH, Papadopoulos S, Schroeter MM, Metzler D, Bust M, Hescheler J, Grisk O, Ritter O, Pfitzer G., Senescent murine femoral arteries undergo vascular remodelling associated with accelerated stress-induced contractility and reactivity to nitric oxide, Basic Clin Pharmacol Toxicol. 2022 Jan;130(1):70-83. doi: 10.1111/bcpt.13675. Epub 2021 Nov 11.PMID: 34665520
  6. Ding WY, Potpara TS, Blomström-Lundqvist C, Boriani G, Marin F, Fauchier L, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry, Eur J Clin Invest. 2022 Jan 9:e13745. doi: 10.1111/eci.13745. Online ahead of print.PMID: 35000206
  7. Patschan D, Marahrens B, Jaensch M, Patschan S, Ritter O. Experimental Cardiorenal Syndrome Type 3: What Is Known so Far?, J Clin Med Res. 2022 Jan;14(1):22-27. doi: 10.14740/jocmr4639. Epub 2022 Jan 29.PMID: 35211213
  8. Hillmeister P, Nagorka S, Gatzke N, Dülsner A, Li K, Dai M, Bondke Persson A, Lauxmann MA, Jaurigue J, Ritter O, Bramlage P, Buschmann E, Buschmann I., Angiotensin-converting enzyme inhibitors stimulate cerebral arteriogenesis, Acta Physiol (Oxf). 2022 Feb;234(2):e13732. doi: 10.1111/apha.13732. Epub 2021 Oct 2.PMID: 34555240
  9. Zeymer U, Toelg R, Wienbergen H, Hobbach HP, Cuneo A, Bekeredjian R, Ritter O, Hailer B, Hertting K, Hennersdorf M, Scholtz W, Lanzer P, Mudra H, Schwefer M, Schwimmbeck PL, Liebetrau C, Thiele H, Claas C, Riemer T, Zahn R. Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany, Herz. 2022 Mar 3. doi: 10.1007/s00059-022-05099-6. Online ahead of print.PMID: 35243515
  10. Drubel K, Marahrens B, Ritter O, Patschan D., Kidney-Related Outcome in Cardiorenal Syndrome Type 3, Int J Nephrol. 2022 Feb 7;2022:4895434. doi: 10.1155/2022/4895434. eCollection 2022.PMID: 35178254
  11. Jaehn P, Sasko B, Holmberg C, Hoffmann S, Spallek J, Kelesidis T, Westhoff TH, Ritter O, Pagonas N, Levels of high-density lipoprotein lipid peroxidation according to spatial socioeconomic deprivation and rurality among patients with coronary artery disease, European Journal of Preventive Cardiology, May 2022
  12. Füller D, Jaehn P, Andresen-Bundus H, Pagonas N, Holmberg C, Christ M, Ritter O, Sasko B, Impact of the Educational Level on Non-Fatal Health Outcomes following Myocardial Infarction, Curr Probl Cardiol. 2022 Jul 30;47(11):101340. doi: 10.1016/j.cpcardiol.2022.101340.

Publikationen 2021

  1. Sasko B., Patschan D., Nordbeck P., Seidlmayer L., Andresen H., Jänsch M., Bramlage P., Ritter O., Pagonas N., Secondary Prevention of Potentially Life-Threatening Arrhythmia Using Implantable Cardioverter Defibrillators in Patients with Biopsy-Proven Viral Myocarditis and Preserved Ejection Fraction, Cardiology, February 05, 2021, doi.org/10.1159/000511120
  2. Reinwald M, Deckert PM, Ritter O, Andresen H, Schreyer AG, Weylandt KH, Dammermann W, Lüth S. Prevalence and Course of IgA and IgG Antibodies against SARS-CoV-2 in Healthcare Workers during the First Wave of the COVID-19 Outbreak in Germany: Interim Results from an Ongoing Observational Cohort Study. Healthcare (Basel). 2021;9(5).
  3. Dihazi H, Schwarze K, Patschan S, Müller GA, Ritter O, Zeisberg M, Patschan D. PAC-Mediated AKI Protection Is Critically Mediated but Does Not Exclusively Depend on Cell-Derived Microvesicles. Int J Nephrol. 2021;2021:8864183.
  4. Ritter O, Kararigas G. In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact. Mayo Clin Proc. 2021;96(3):821-822.
  5. Andresen H, Sasko B, Patschan D, Pagonas N, Ritter O. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report. J Med Case Rep. 2021;15(1):243.
  6. Ghafoor H, Nordbeck P, Ritter O, Pauli P, Schulz SM. Can Religiosity and Social Support Explain Effects of Trait Emotional Intelligence on Health-Related Quality of Life: A Cross-Cultural Study. J Relig Health. 2021.
  7. Markakis K, Pagonas N, Georgianou E, Zgoura P, Rohn BJ, Bertram S, Seidel M, Bettag S, Trappe HJ, Babel N, Westhoff TH, Seibert FS. Feasibility of non-invasive measurement of central blood pressure and arterial stiffness in shock. Eur J Clin Invest. 2021;e13587.
  8. Seidel M, Pagonas N, Seibert FS, Bauer F, Rohn B, Vlatsas S, Mühlberger D, Nina B, Westhoff TH. The differential impact of aerobic and isometric handgrip exercise on blood pressure variability and central aortic blood pressure. J Hypertens. 2021;39(7):1269-1273.
  9. Asmus K, Erfurt S, Ritter O, Patschan S, Patschan D. AKI Epidemiology and Outcomes: A Retrospective Cohort Study from the Prenephrology Era. Int J Nephrol. 2021;2021:5549316.
  10. Erfurt S, Hoffmeister M, Oess S, Asmus K, Ritter O, Patschan S, Patschan D. Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification?; J Circ Biomark. 2021 Nov 30;10:20-25.
  11. Hillmeister P, Nagorka S, Gatzke N, Dülsner A, Li K, Dai M, Bondke Persson A, Lauxmann MA, Jaurigue J, Ritter O, Bramlage P, Buschmann E, Buschmann I., Angiotensin-converting enzyme inhibitors stimulate cerebral arteriogenesis.Acta Physiol (Oxf). 2021 Sep 23:e13732.
  12. Lubomirov LT, Jänsch MH, Papadopoulos S, Schroeter MM, Metzler D, Bust M, Hescheler J, Grisk O, Ritter O, Pfitzer G. Senescent murine femoral arteries undergo vascular remodelling associated with accelerated stress-induced contractility and reactivity to nitric oxide, Basic Clin Pharmacol Toxicol. 2022 Jan;130(1):70-83. doi: 10.1111/bcpt.13675. Epub 2021 Nov 11.
  13. Seckinger D, Ritter O, Patschan D., Risk factors and outcome variables of cardiorenal syndrome type 1 from the nephrologist's perspective. Int Urol Nephrol. 2021 Oct 28.
  14. Greffin K, Muehlan H, van den Berg N, Hoffmann W, Ritter O, Oeff M, Schomerus G, Schmidt S. Setting-Sensitive Conceptualization and Assessment of Quality of Life in Telemedical Care-Study Protocol of the Tele-QoL Project, Int J Environ Res Public Health. 2021 Oct 5;18(19):10454.
  15. Greffin K, Schmidt S, van den Berg N, Hoffmann W, Ritter O, Oeff M, Schomerus G, Muehlan H. Same same-but different: using qualitative studies to inform concept elicitation for quality of life assessment in telemedical care: a request for an extended working model, Health Qual Life Outcomes. 2021 Jul 5;19(1):175.
  16. Seibert FS, Heringhaus A, Pagonas N, Rohn B, Bauer F, Trappe HJ, Landmesser U, Babel N, Westhoff TH. Dickkopf-3 in the prediction of contrast media induced acute kidney injury,J Nephrol. 2021 Jun;34(3):821-828.

Publikationen 2020

  1. Patschan D, Schwarze K, Tampe B, Becker JU, Hakroush S, Ritter O, Patschan S, Müller GA; Constitutive Atg5 overexpression in mouse bone marrow endothelial progenitor cells improves experimental acute kidney injury; BMC Nephrol. 2020; 21: 503. Published online 2020 Nov 23. doi: 10.1186/s12882-020-02149-1
  2. Patschan S, Bothmann L, Patschan D, Henze E, Schmalz G, Ritter O., Ziebolz D; Association of cytokine patterns and clinical/laboratory parameters, medication and periodontal burden in patients with rheumatoid arthritis (RA); Odontology. 2020; 108(3): 441–449. Published online 2020 Apr 16. doi: 10.1007/s10266-020-00517-9
  3. Sasko B, Ritter O, Bramlage P, Riediger F; Late left atrial appendage closure device displacement and massive thrombus formation: a case report; Eur Heart J Case Rep. 2020 Jun; 4(2): 1–5. Published online 2020 Feb 20. doi: 10.1093/ehjcr/ytaa014
  4. Ritter O, Kararigas G; Sex-Biased Vulnerability of the Heart to COVID-19; Mayo Clin Proc. 2020 Nov; 95(11): 2332–2335. Published online 2020 Sep 18. doi: 10.1016/j.mayocp.2020.09.017
  5. Seibert FS, Heringhaus A, Pagonas N, Rudolf H, Rohn B, Bauer F, Timmesfeld N, Trappe HJ, Babel N, Westhoff TH; Biomarkers in the prediction of contrast media induced nephropathy – the BITCOIN study; PLoS One. 2020; 15(7): e0234921. Published online 2020 Jul 16. doi: 10.1371/journal.pone.0234921
  6. Pagonas N, Bauer F, Zappe L, Seibert FS, Rohn B, Klimek C, Wirth R, Gotzmann M, Babel N, Westhoff TH; Hemodynamic Effects of a Multidisciplinary Geriatric Rehabilitation Program; Clin Interv Aging. 2020; 15: 1035–1043. Published online 2020 Jun 30. doi: 10.2147/CIA.S239844
  7. Seibert FS, Heringhaus A, Pagonas N, Rohn B, Bauer F, Trappe HJ, Landmesser U, Babel N, Westhoff TH. Dickkopf-3 in the prediction of contrast media induced acute kidney injury. J Nephrol. 2020 Dec 4. doi: 10.1007/s40620-020-00910-1. Online ahead of print. PMID: 33275197
  8. Patschan D, Patschan S, Ritter O. Chronic Metabolic Acidosis in Chronic Kidney Disease. Kidney Blood Press Res. 2020;45(6):812-822. doi: 10.1159/000510829. Epub 2020 Dec 2. PMID: 33264780 Free article. Review
  9. Matyukhin I, Patschan S, Ritter O, Patschan D. Etiology and Management of Acute Metabolic Acidosis: An Update. Kidney Blood Press Res. 2020;45(4):523-531. doi: 10.1159/000507813. Epub 2020 Jul 14. PMID: 32663831 Free article. Review
  10. Proietti M, Lip GYH, Laroche C, Fauchier L, Marin F, Nabauer M, Potpara T, Dan GA, Kalarus Z, Tavazzi L, Maggioni AP, Boriani G; ESC-EORP Atrial Fibrillation General Long-Term Registry Investigators Group. Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry. Europace. 2020 Oct 2:euaa274. doi: 10.1093/europace/euaa274. Online ahead of print. PMID: 33006613

Zurück